Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
European Journal of Pharmacology
|
December 25, 2022
Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway
Shiji Fang, Liyun Zheng, Lin Shen, et al.
Journal of Nanobiotechnology
|
April 3, 2022
Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization
Minjiang Chen, Jie Li, Gaofeng Shu, et al.
JAMA Oncology
|
July 10, 2025
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer: A Randomized Clinical Trial
Han Xiao, Jiansong Ji, Shaoqiang Li, et al.
ACS Nano
|
March 11, 2024
Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular Carcinoma
Shiji Fang, Liyun Zheng, Gao-Feng Shu, et al.
Hepatology International
|
July 17, 2023
MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way
Shiji Fang, Liyun Zheng, Xiaoxiao Chen, et al.
Experimental Cell Research
|
January 23, 2017
Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer
Min Xu, Zhongwei Zhao, Jingjing Song, et al.
Lipids in Health and Disease
|
October 1, 2024
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinoma
Yanran Bi, Xihui Ying, Wanbin Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 25, 2020
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
Zhongwei Zhao, Jingjing Song, Bufu Tang, et al.
Biomaterials Science
|
July 3, 2023
Recombinant supercharged polypeptides for safe and efficient heparin neutralization
Jianfei Tu, Qing Liu, Shengye You, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 8, 2026
KAT2B inhibits cholangiocarcinoma proliferation by binding with histone demethylase KDM6B
Rongfang Qiu, Ziwei Xu, Hui Meng, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
European Journal of Pharmacology
|
December 25, 2022
Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway
Shiji Fang, Liyun Zheng, Lin Shen, et al.
Journal of Nanobiotechnology
|
April 3, 2022
Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization
Minjiang Chen, Jie Li, Gaofeng Shu, et al.
JAMA Oncology
|
July 10, 2025
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer: A Randomized Clinical Trial
Han Xiao, Jiansong Ji, Shaoqiang Li, et al.
ACS Nano
|
March 11, 2024
Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular Carcinoma
Shiji Fang, Liyun Zheng, Gao-Feng Shu, et al.
Hepatology International
|
July 17, 2023
MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way
Shiji Fang, Liyun Zheng, Xiaoxiao Chen, et al.
Experimental Cell Research
|
January 23, 2017
Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer
Min Xu, Zhongwei Zhao, Jingjing Song, et al.
Lipids in Health and Disease
|
October 1, 2024
Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinoma
Yanran Bi, Xihui Ying, Wanbin Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 25, 2020
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
Zhongwei Zhao, Jingjing Song, Bufu Tang, et al.
Biomaterials Science
|
July 3, 2023
Recombinant supercharged polypeptides for safe and efficient heparin neutralization
Jianfei Tu, Qing Liu, Shengye You, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 8, 2026
KAT2B inhibits cholangiocarcinoma proliferation by binding with histone demethylase KDM6B
Rongfang Qiu, Ziwei Xu, Hui Meng, et al.
Page
of 11